Circle Pharma Strengthens Its Executive Leadership Team with Two Senior Appointments in Clinical Development
Company
Circle Pharma
South San FranciscoHealthcareHealth CareDescription
Circle Pharma, a biopharmaceutical company advancing the discovery and development of intrinsically cell-permeable macrocycles, announced today the appointments of Michael Cox, PharmD., MHSc, BCOP as senior vice president, head of Early Development, and Edward Garmey, M.D., as its new consulting chief medical officer. These additions to the leadership team further bolster Circle Pharma's capabilities in oncology drug development as it advances its Cyclin A/B inhibitor program into clinical studies. In addition to Dr. Cox's appointment, Circle Pharma is pleased to welcome Edward Garmey, M.D., as the new consulting Chief Medical Officer
Who to call at Circle Pharma, and when
A new leader at Circle Pharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Circle Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Circle Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Circle Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Circle Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Circle Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.